|
|
|||
|
||||
OverviewThis book covers the unique application of flow cytometry in drug discovery and development. The first section includes two introductory chapters, one on flow cytometry and one on biomarkers, as well as a chapter on recent advances in flow cytometry. The second section focuses on the unique challenges and added benefits associated with the use of flow cytometry in the drug development process. The third section contains a single chapter presenting an in depth discussion of validation considerations and regulatory compliance issues associated with drug development. Full Product DetailsAuthor: Virginia Litwin (University of California; University of Iowa) , Philip Marder (Ohio State University)Publisher: John Wiley & Sons Inc Imprint: John Wiley & Sons Inc Dimensions: Width: 16.30cm , Height: 2.50cm , Length: 24.90cm Weight: 0.676kg ISBN: 9780470433560ISBN 10: 0470433566 Pages: 376 Publication Date: 20 December 2010 Audience: Professional and scholarly , Professional & Vocational Replaced By: 9781394240265 Format: Hardback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsThis book covers the unique application of flow cytometry in drug discovery and development. (Smart Grid, 15 February 2011) <p> This book covers the unique application of flow cytometry in drug discovery and development. (Laboratory Journal, 22 December 2010) This book covers the unique application of flow cytometry in drug discovery and development. (Smart Grid, 15 February 2011)<p> This book covers the unique application of flow cytometry in drug discovery and development. (Laboratory Journal, 22 December 2010) Author InformationVirginia Litwin is a Principal Scientist at Covance Central Laboratory Services. After numerous years in the pharmaceutical/biotechnology industry, she has become a leader in the application and validation of flow cytometric methods in drug discovery and development. She founded the Flow Cytometry Subcommittee of the Ligand Binding Assay Bioanalytical Focus Group within the American Association of Pharmaceutical Scientists (AAPS). She is an active contributor to the International Clinical Cytometry Society (ICCS) and the International Society for Analytical Cytology (ISAC). She received her bachelor's from the University of California and her doctorate from the University of Iowa. Philip Marder was internationally distinguished for his leadership in the application of flow cytometry in early drug discovery and development. He was a key contributor to the scientific community as an active member of ISAC and AAPS. After receiving both his bachelor's and master's degrees from The Ohio State University, he had a distinguished thirty year career at Eli Lilly and Company. Tab Content 6Author Website:Countries AvailableAll regions |
||||